These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18773863)

  • 21. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
    Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma.
    Wang Q; Shen Y; Wang P; Li X
    J Cancer Res Ther; 2013; 9(2):250-2. PubMed ID: 23771368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].
    Zhao YN; Cao J; Wu FX; Ou C; Yuan WP; Mo QG; Wei W; Li Y; Su JJ; Liang AM
    Ai Zheng; 2004 Jul; 23(7):762-6. PubMed ID: 15248908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.
    Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF
    Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparanase mRNA expression and point mutation in hepatocellular carcinoma.
    Chen XP; Liu YB; Rui J; Peng SY; Peng CH; Zhou ZY; Shi LH; Shen HW; Xu B
    World J Gastroenterol; 2004 Oct; 10(19):2795-9. PubMed ID: 15334672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma.
    Chen B; Chen XP; Wu MS; Cui W; Zhong M
    Eur J Med Res; 2014 Aug; 19(1):45. PubMed ID: 25149140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma].
    Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
    Arii S; Mise M; Harada T; Furutani M; Ishigami S; Niwano M; Mizumoto M; Fukumoto M; Imamura M
    Hepatology; 1996 Aug; 24(2):316-22. PubMed ID: 8690399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
    Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
    J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.